JPRN-UMIN000036706
Completed
未知
Immune checkpoint inhibitor versus chemotherapy for elderly non-small cell lung cancer:a meta-analysis - ICI for elderly NSCLC
Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine0 sites1,920 target enrollmentMay 13, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine
- Enrollment
- 1920
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients with non\-small cell lung cancer aged less than 65 years.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Stereotactic Body Radiation in combination with immunotherapy-chemotherapy in patients with Metastatic Non-Small Cell Lung Cancer.Patients with both squamous and nonsquamous metastatic non-small cell lung cancer (NSCLC) wild type in EGFR, KRAS, ALK and ROS1.MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-002453-28-ITAZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA132
Recruiting
Not Applicable
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung CancerNon Small Cell Lung CancerNCT05059951Hunan Province Tumor Hospital15,000
Not yet recruiting
Not Applicable
Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High-Intensity Focused Ultrasound Histotripsy; the iFOCUS study.cancermalignancy10027655NL-OMON56837niversitair Medisch Centrum Utrecht24
Not yet recruiting
Not Applicable
Immune checkpoint inhibitor therapy for advanced, recurrent or metastatic non-small cell lung cancer with low or negative PD-L1 expression.JPRN-UMIN000050723Kobe University200
Completed
Not Applicable
Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer other than adenocarcinoma or squamous cell carcinoma: multicenter retrospective observational studyon-small cell lung cancer other than adenocarcinoma or squamous cell carcinomaJPRN-UMIN000037777Hamamatsu University School of Medicine60